Navigation Links
New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
Date:1/14/2009

pseudoephedrine, now located behind the counter; CHILDREN'S CLARITIN(R) Syrup, a liquid formulation for children ages 2 and older in grape and fruit flavors; and CHILDREN'S CLARITIN(R) Grape Chewables, a chewable tablet for children ages 2 and older.

CLARITIN(R) is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN(R) Rx-to-OTC switch in 2002 was the largest switch ever--and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for CLARITIN Liqui-Gels. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
2. $1 Million Available to Help Michigans Uninsured Receive Care
3. ORSupply.com Unveils Largest Selection of Otoscopes Available Anywhere
4. Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide
5. Guide on Blood Thinner Now Available in Spanish
6. Patients Benefit From Mobicosa, A Unique, Natural Arthritis Treatment Available At Your Chemist Shop
7. EyeSciences New Ocular Nutrition Supplements Available at CVS Stores
8. Plastic Surgery Experts Available to Comment on Face Transplant Surgery
9. North Carolina Student Loan Program for Health, Science and Mathematics Application Will Be Available December 20, 2008
10. Millennium Research Group Analyst Available to Comment on FDAs Premarket Approval Recommendation of Genzyme Biosurgerys Synvisc Single-Injection Product for the Knee
11. Trimma(TM) Now Available in the United States for People Looking for a Delicious Way to Control Their Calories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... about the chance of ,overdiagnosis, through the NHS breast ... according to research published in the British Journal ... survey of around 2,200 women, Cancer Research UK scientists ... cent felt they fully understood the information given about ... cancers that would never have gone on to cause ...
(Date:8/28/2014)... Millennium Treatment Group is excited ... month will be a celebration of the positive ... Along with other treatment facilities and mental health ... the word about this national observance. , National ... of treatment and recovery professionals, and has since ...
(Date:8/28/2014)... Millennium Treatment Group has noticed a ... workplace. A recent report from the National Council ... drug abuse is costing employers an estimated $81 billion ... to drugs affect their employers and the company they ... workplace, causing expensive problems for their employers, such as ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, 2014 (HealthDay ... symptoms of multiple sclerosis (MS), a new study from Argentina ... D, smoking and Epstein Barr virus infection. Our study shows ... MS patients," said lead researcher Dr. Mauricio Farez, of the ... Multiple sclerosis is a disease of the nervous system that ...
(Date:8/28/2014)... 2014 Testimony began this week ... transvaginal mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ )involving a ... reports. Court documents pending in the U.S. District ... the case was filed on behalf of a ... allegedly due to vaginal mesh complications associated with ...
Breaking Medicine News(10 mins):Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 4
... [Brown University] More than 1.4 million Americans live ... million will need long-term care, whether in a nursing ... an at-home health service provider. , At this time ... on Aging has awarded Brown University a major grant ...
... 15 Danny Wright, Chief Executive Officer,of Alliance ... will be featured in an exclusive interview,with ... p.m. EST. The interview,will be posted on ... 16. The interview will cover topics including ...
... The Center for State and,Local Government Excellence ... Public Policy and Social Research (IPPSR) at Michigan ... the state,s unfunded retiree health,care liability. Michigan ... billion. To help policy leaders develop thoughtful solutions, ...
... NovaBay,Pharmaceuticals, Inc. (AMEX & TSX: NBY), a biopharmaceutical ... or prevention of a wide range of bacterial ... quarter ended September 30, 2007. Net loss ... $1.6 million, or,$0.24 per share, as compared to ...
... United States are estimated to already have bone diseases, ... low bone mass, putting them at increased risk for ... Wang, assistant professor of mechanical engineering at the University ... Two of Wang,s aunts have suffered from the insidious ...
... when a naturally occurring hormone in your body turns against ... melatonin is a popular supplement you take to ... his team of researchers may have some answers. ... biology and biochemistry at UH, describes his teams findings in ...
Cached Medicine News:Health News:Brown to create most comprehensive long-term care database 2Health News:Brown to create most comprehensive long-term care database 3Health News:WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard 2Health News:Center For Excellence to Fund Analysis of Michigan State Retiree Health Care Reforms 2Health News:NovaBay announces third quarter 2007 financial results 2Health News:NovaBay announces third quarter 2007 financial results 3Health News:NovaBay announces third quarter 2007 financial results 4Health News:NovaBay announces third quarter 2007 financial results 5Health News:NovaBay announces third quarter 2007 financial results 6Health News:NovaBay announces third quarter 2007 financial results 7Health News:Bad to the bone: UD research to shed light on osteoporosis 2Health News:Bad to the bone: UD research to shed light on osteoporosis 3Health News:The hormone of darkness: melatonin could hurt memory formation at night 2Health News:The hormone of darkness: melatonin could hurt memory formation at night 3
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)... 28, 2014 Nonin Medical, Inc., the inventor ... medical monitoring, today announced that the Food and Drug ... finger pulse oximeter for use in the ... into a telemedicine hub or kiosk through a USB ... pediatric to adult patients. The Model 3231 received EU ...
(Date:8/28/2014)... Oregon , August 28, 2014 ... Research titled, "DNA diagnostics Market (products, applications, techniques, ... Trends, Opportunities, Growth and Forecast, 2013 - 2020," ... reach $19 billion by 2020 registering a CAGR ... to provide accurate diagnosis and cost effectiveness over ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... 2011 Quest Diagnostics Incorporated (NYSE: DGX ... and services, today announced the CE mark and European ... test on the 3M™ Integrated Cycler.  The new test, ... technique to eliminate nucleic-acid sample extraction, a time-consuming process ...
... N.J., Nov. 1, 2011 MedAvante, Inc., the world,s ... of treatments for central nervous system (CNS) disorders, announced ... 2011 Fifty Fastest Growing Companies. NJBIZ, New ... 50 Fastest Growing Companies in celebration of New Jersey,s ...
Cached Medicine Technology:Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 2Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 3MedAvante Is One of NJ's Fastest Growing Companies 2
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
Medicine Products: